Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Kristina M Harris
Affiliation
University of California san francisco
ORCID
Career Start Year
2006
Papers
36
H Index
22
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36041516
Stabilization of leukocytes from cerebrospinal fluid for central immunophenotypic evaluation in multicenter clinical trials.
J Immunol Methods
2022
34643650
Effect of Costimulatory Blockade With Abatacept After Ustekinumab Withdrawal in Patients With Moderate to Severe Plaque Psoriasis: The PAUSE Randomized Clinical Trial.
JAMA Dermatol
2021
33819508
Differential induction of allergen-specific IgA responses following timothy grass subcutaneous and sublingual immunotherapy.
J Allergy Clin Immunol
2021
33504809
A CD8<sup>+</sup> NK cell transcriptomic signature associated with clinical outcome in relapsing remitting multiple sclerosis.
Nat Commun
2021
35072168
A phase 1b open-label dose-finding study of ustekinumab in young adults with type 1 diabetes.
Immunother Adv
2021
34618687
Circulating autoreactive proteinase 3+ B cells and tolerance checkpoints in ANCA-associated vasculitis.
JCI Insight
2021
32311390
Biomarkers of severity and threshold of allergic reactions during oral peanut challenges.
J Allergy Clin Immunol
2020
31877116
Extensive intrathecal T cell renewal following hematopoietic transplantation for multiple sclerosis.
JCI Insight
2020
30683697
Abatacept Targets T Follicular Helper and Regulatory T Cells, Disrupting Molecular Pathways That Regulate Their Proliferation and Maintenance.
J Immunol
2019
31293002
Elicited and pre-existing anti-Neu5Gc antibodies differentially affect human endothelial cells transcriptome.
Xenotransplantation
2019
29128670
Synchronous immune alterations mirror clinical response during allergen immunotherapy.
J Allergy Clin Immunol
2018
29473705
Alpha-1 antitrypsin treatment of new-onset type 1 diabetes: An open-label, phase I clinical trial (RETAIN) to assess safety and pharmacokinetics.
Pediatr Diabetes
2018
29456529
Challenges and Opportunities for Biomarkers of Clinical Response to AHSCT in Autoimmunity.
Front Immunol
2018
28844471
Remodeling T cell compartments during anti-CD3 immunotherapy of type 1 diabetes.
Cell Immunol
2017
28198767
Anti-Gal and Anti-Neu5Gc Responses in Nonimmunosuppressed Patients After Treatment With Rabbit Antithymocyte Polyclonal IgGs.
Transplantation
2017
28196255
Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial.
JAMA
2017
28498568
Reconstitution of immune cell populations in multiple sclerosis patients after autologous stem cell transplantation.
Clin Exp Immunol
2017
29348821
Glycan microarray reveal induced IgGs repertoire shift against a dietary carbohydrate in response to rabbit anti-human thymocyte therapy.
Oncotarget
2017
27053235
Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trial.
Diabetologia
2016
28664195
Partial exhaustion of CD8 T cells and clinical response to teplizumab in new-onset type 1 diabetes.
Sci Immunol
2016
26518356
Changes in T-cell subsets identify responders to FcR-nonbinding anti-CD3 mAb (teplizumab) in patients with type 1 diabetes.
Eur J Immunol
2016
26942922
Effect of Avoidance on Peanut Allergy after Early Peanut Consumption.
N Engl J Med
2016
25546364
High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim report.
JAMA Neurol
2015
26405570
Depletion of B220<sup>+</sup>NK1.1<sup>+</sup> cells enhances the rejection of established melanoma by tumor-specific CD4<sup>+</sup> T cells.
Oncoimmunology
2015
26193635
Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients.
J Clin Invest
2015
24643777
The IL-23/Th17 axis is involved in the adaptive immune response to Bacillus anthracis in humans.
Eur J Immunol
2014
25227493
Vγ2Vδ2 T cell Costimulation Increases NK cell Killing of Monocyte-derived Dendritic Cells.
Immunology
2014
23493729
A peptide antagonist of CD28 signaling attenuates toxic shock and necrotizing soft-tissue infection induced by Streptococcus pyogenes.
J Infect Dis
2013
23536636
Restoring immune function of tumor-specific CD4+ T cells during recurrence of melanoma.
J Immunol
2013
21724805
Monocytes differentiated with GM-CSF and IL-15 initiate Th17 and Th1 responses that are contact-dependent and mediated by IL-15.
J Leukoc Biol
2011
20153259
Monocytes differentiated with IL-15 support Th17 and Th1 responses to wheat gliadin: implications for celiac disease.
Clin Immunol
2010
19335774
The microaerophilic flagellate, Trichomonas vaginalis, contains unusual acyl lipids but no detectable cardiolipin.
J Eukaryot Microbiol
2009
19769735
Combining conventional therapies with intratumoral injection of autologous dendritic cells and activated T cells to treat patients with advanced cancers.
Ann N Y Acad Sci
2009
18691939
Products of anti-CD3/anti-CD28 activated lymphocytes induce differentiation and maturation of dendritic cells and have adjuvant-like activity in vitro and in vivo.
Clin Immunol
2008
18802048
Cutting edge: IL-1 controls the IL-23 response induced by gliadin, the etiologic agent in celiac disease.
J Immunol
2008
17169054
Trichomonas vaginalis and Giardia intestinalis produce nitric oxide and display NO-synthase activity.
J Eukaryot Microbiol
2006
1 - 36 of 36
Column Actions
Search
Recommended Authors
Maigan A Brusko
University of Florida
Career Start Year
2017
Number of shared co-authors
0
Paulo Czarnewski
Karolinska Institute, Center for Molecular Medicine
Career Start Year
2012
Number of shared co-authors
0
Alexander F Rosenberg
University of Alabama at Birmingham Birmingham
Career Start Year
2011
Number of shared co-authors
0
Angelika Schmidt
Institute for Immunology, Biomedical Center (BMC)
Career Start Year
2009
Number of shared co-authors
0
Cate Speake
Center for Interventional Immunology, Benaroya Research Institute at Virginia Mason
Career Start Year
2009
Number of shared co-authors
13
Alice E Wiedeman
Center for Translational Immunology, Benaroya Research Institute at Virginia Mason
Career Start Year
2007
Number of shared co-authors
7
Marc Veldhoen
Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa
Career Start Year
2005
Number of shared co-authors
0
Tony J Kenna
Queensland University of Technology
Career Start Year
2004
Number of shared co-authors
0
Jonathan L Linehan
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year
2004
Number of shared co-authors
0
Todd M Brusko
College of Medicine, Diabetes Institute, University of Florida
Career Start Year
2003
Number of shared co-authors
9
Johnna D Wesley
Novo Nordisk Research Center Seattle, Inc.
Career Start Year
2003
Number of shared co-authors
2
Marcin Moniuszko
Medical University of Bialystok
Career Start Year
2001
Number of shared co-authors
0
Martin Prlic
Fred Hutchinson Cancer Research Center
Career Start Year
2001
Number of shared co-authors
8
Ning Jiang
The University of Texas at Austin
Career Start Year
2000
Number of shared co-authors
0
Miriam Merad
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year
2000
Number of shared co-authors
0
John T Chang
University of California San Diego
Career Start Year
1999
Number of shared co-authors
0
Cristina M Tato
Institute of Immunity, Stanford University School of Medicine
Career Start Year
1998
Number of shared co-authors
0
Insoo Kang
Yale School of Medicine
Career Start Year
1997
Number of shared co-authors
1
Seunghee Kim-Schulze
Icahn School of Medicine at Mount Sinai
Career Start Year
1996
Number of shared co-authors
0
Francesca Fallarino
University of Perugia
Career Start Year
1995
Number of shared co-authors
0
Daniel J Cua
Merck & Co., Inc.
Career Start Year
1994
Number of shared co-authors
0
Thomas Korn
TUM School of Medicine, Technical University of Munich
Career Start Year
1993
Number of shared co-authors
0
Bali Pulendran
Institute for Immunity, Stanford University School of Medicine, Stanford University
Career Start Year
1990
Number of shared co-authors
0
Michael J Clare-Salzler
University of Florida College of Medicine
Career Start Year
1989
Number of shared co-authors
3
Qi Wu
University of Michigan Medical School
Career Start Year
1989
Number of shared co-authors
0
Clare Baecher-Allan
Brigham and Women's Hospital, Harvard Medical School
Career Start Year
1988
Number of shared co-authors
1
Casey T Weaver
University of Alabama at Birmingham
Career Start Year
1986
Number of shared co-authors
1
Maura Rossetti
University of California Los Angeles
Career Start Year
1986
Number of shared co-authors
0
Penelope A Morel
University of Pittsburgh
Career Start Year
1982
Number of shared co-authors
0
David A Hafler
Yale School of Medicine, Yale School of Public Health
Career Start Year
1981
Number of shared co-authors
6
row(s) 1 - 30 of 30
Collaborators
Noha Lim
Co-authored papers
10
Mario R Ehlers
Clinical Trials Group
Co-authored papers
8
Gerald T Nepom
Wash Benaroya Research Institute at Virginia Mason
Co-authored papers
6
Sarah Alice Long
Center for Translational Immunology, Benaroya Research Institute at Virginia Mason
Co-authored papers
5
Alkis Togias
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers
3
Kevan C Herold
Yale University
Co-authored papers
3
Steven M Willi
Children's Hospital of Philadelphia
Co-authored papers
2
Peter S Linsley
8Benaroya Research Institute
Co-authored papers
2
Jerill Thorpe
Benaroya Research Institute at Virginia Mason
Co-authored papers
2
Robert Bissonnette
Co-authored papers
1
Gerald G Krueger
Co-authored papers
1
Erik Wambre
Precision Immunology Institute, Icahn School of Medicine at Mount Sinai
Co-authored papers
1
Michael K Racke
The Ohio State University Wexner Medical Center
Co-authored papers
1
Colin O'Rourke
Center for Interventional Immunology, Benaroya Research Institute at Virginia Mason
Co-authored papers
1
William W Kwok
Center for Translational Immunology, Benaroya Research Institute at Virginia Mason
Co-authored papers
1
Carla J Greenbaum
Center for Interventional Immunology, Benaroya Research Institute at Virginia Mason
Co-authored papers
1
Jane H Buckner
Center for Translational Immunology, Benaroya Research Institute at Virginia Mason
Co-authored papers
1
James A Eddy
Benaroya Research Institute at Virginia Mason, Institute for Systems Biology, Sage Bionetworks, University of Illinois at Urbana-Champaign
Co-authored papers
1
Scott S Zamvil
Weill Institute for Neurosciences, University of California san francisco
Co-authored papers
1
Tobias Zrzavy
Co-authored papers
1
Chris Cotsapas
Co-authored papers
1
Steven M Opal
Infectious Disease Division at Brown University Warren Alpert Medical School
Co-authored papers
1
Jie Sun
Co-authored papers
1
Peter A Merkel
University of Pennsylvania Perelman School of Medicine
Co-authored papers
1
Vivian H Gersuk
Center for Systems Immunology, Benaroya Research Institute
Co-authored papers
1
Petra Lenz
Frederick National Laboratory for Cancer Research
Co-authored papers
1
Holden T Maecker
Co-authored papers
1
Sarah Bruneau
Centre Hospitalier Universitaire de Nantes, Nantes Universite, Inserm
Co-authored papers
1
James D Bowen
Swedish Neuroscience Institute
Co-authored papers
1
Hannah A DeBerg
Benaroya Research Institute at Virginia Mason
Co-authored papers
1
1 - 30